SAN DIEGO, CA--(Marketwired - November 19, 2014) - SpectraScience, Inc. (OTCQB: SCIE), a San Diego-based medical device company, today announced that Michael Oliver, President and Chief Executive Officer, will make a presentation at the LD Micro conference on Wednesday, December 3rd, 2014 at 9:30 AM PST / 12:30 PM EST.
“We are honored to have SpectraScience present at the Main Event this year,” stated Chris Lahiji, Founder of LD Micro.
About SpectraScience, Inc.
SpectraScience is a San Diego based medical device company that designs, develops, manufactures and markets spectrophotometry systems capable of determining whether tissue is normal, pre-cancerous or cancerous without physically removing tissue from the body. The WavSTAT™ Optical Biopsy System uses light to optically scan tissue and provide the physician with an immediate analysis. With FDA approval for sale in the U.S. and the CE Mark for the European Union, the WavSTAT System is the first commercially available product that incorporates this innovative technology for clinical use. The Company’s LUMA imaging technology has received FDA approval for an optical non-invasive system that is proven to more effectively detect cervical cancer precursors than conventional methods available in the market today.
About LD Micro
LD Micro is an investment newsletter firm that focuses on finding undervalued companies in the micro-cap space. Since 2002, the firm has published reports on select companies throughout the year. The firm also hosts the LD Micro Invitational. It is a non-registered investment advisor. For more information, please contact 408-457-1042 or visit www.ldmicro.com.
Contact:
SpectraScience, Inc.
Lowell Giffhorn
Chief Financial Officer
(858) 847-0200
Help employers find you! Check out all the jobs and post your resume.
